160 results

• Dupixent Cancer Risks Lead Experts to Recommend Skin Biopsies Before Treatment

  October 16, 2026

  Irvin Jackson

  A group of dermatologists and pathologists have reached a consensus opinion recommending doctors screen patients for CTCL before and during treatment with Dupixent.

• Dupixent Side Effects Lawsuit Alleges Drug Caused Cutaneous T-Cell Lymphoma

  September 24, 2026

  Irvin Jackson

  A woman's Dupixent cancer lawsuit alleges that the manufacturers should have known the eczema treatment caused a rare form of T-cell lymphoma and warned doctors and patients.

• Dupixent Side Effects Caused CTCL, Tumors, Lawsuit Alleges

  September 10, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit claims using the eczema treatment led to a man's cancer returning, leaving him with life-long medical treatment needs.

• Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis

  August 20, 2026

  Irvin Jackson

  A California woman's Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug's cancer risks, but refused to inform doctors and patients.

• Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges

  August 11, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.

• CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use

  July 29, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit claims that the manufacturer intentionally failed to warn patients or the medical community about the eczema treatment's potential cancer risks.

• Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis

  July 21, 2026

  Irvin Jackson

  A Dupixent cancer lawsuit claims the manufacturers failed to adequately test and label the eczema treatment, resulting in a CTCL cancer diagnosis.

• Taxotere Watery Eyes Lawsuits Cleared To Move Forward Over Inadequate Side Effect Warnings

  July 8, 2026

  Irvin Jackson

  A federal judge is allowing Taxotere watery eyes lawsuits to move forward, giving plaintiffs an opportunity to convince juries that the cancer drug's label warnings are inadequate.

• Lawsuit Claims Dupixent Cancer Diagnosis Occurred After Only 8 Months of Use

  June 17, 2026

  Irvin Jackson

  The makers of Dupixent face a CTCL lawsuit by a man who says he developed the rare form of cancer less than a year after beginning treatment with the eczema drug.

• Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy

  May 1, 2026

  Irvin Jackson

  A Dupixent lawsuit claims use of the drug led to the diagnosis of two forms of CTCL cancer, requiring repeated chemotherapy treatment and life-long medical monitoring.